E-LIB Suche - Ergebnisse für: Chiricozzi, A.

1

Efficacy and Safety of Secukinumab in Elderly Patients with..:

Talamonti M ; Russo F ; Malara G...
https://www.dovepress.com/efficacy-and-safety-of-secukinumab-in-elderly-patients-with-moderate-t-peer-reviewed-fulltext-article-CCID. , 2023

Link: https://doaj.org/article..

2

Beneficial effects of upadacitinib on alopecia areata assoc..:

Chiricozzi A ; Balato A ; Fabbrocini G...
firstpage:1251. , 2023

Link: https://hdl.handle.net/1..

3

Brodalumab for the treatment of moderate-to-severe psoriasi..:

Fargnoli M. C ; Bardazzi F ; Bianchi L...
info:eu-repo/semantics/altIdentifier/pmid/37240650. , 2023

Link: https://hdl.handle.net/1..

4

Overview of Atopic Dermatitis in Different Ethnic Groups:

Chiricozzi A ; Maurelli M ; Calabrese L..
info:eu-repo/semantics/altIdentifier/pmid/37048783. , 2023

Link: https://hdl.handle.net/1..

5

Current treatment goals are achieved by the majority of pat..:

A Chiricozzi ; SM Ferrucci ; L Di Nardo...
firstpage:1307. , 2023

Link: https://hdl.handle.net/1..

6

Case report: Dupilumab treatment improved type 2 disorders ..:

Caruso, C ; Laterza, L ; Settanni, C. R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875030/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Case report: Dupilumab treatment improved type 2 disorders ..:

C. Caruso ; L. Laterza ; C. R. Settanni...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.995304/full. , 2023

Link: https://doi.org/10.3389/..

8

Analysis of predictive factors influencing dupilumab contin..:

Gori N ; Sernicola A ; Tolino E...
info:eu-repo/semantics/altIdentifier/pmid/37400981. , 2023

Link: https://hdl.handle.net/1..

9

Current treatment goals are achieved by the majority of pat..:

A Chiricozzi ; SM Ferrucci ; L Di Nardo...
doi:10.6084/m9.figshare.24851040.v1. , 2023

Link: https://doi.org/10.6084/..

10

The immunobiology of the skin in response to the environmen:

E. Donetti ; M. Sommariva ; A. Chiricozzi.
info:eu-repo/semantics/altIdentifier/wos/WOS:001000781300001. , 2023

Link: https://hdl.handle.net/2..

11

Investigational systemic drugs for moderate to severe plaqu..:

Calabrese L ; Malvaso D ; Antonelli F...
info:eu-repo/semantics/altIdentifier/pmid/36852779. , 2023

Link: https://hdl.handle.net/1..

12

Therapeutic Impact and Management of Persistent Head and Ne..:

Chiricozzi A ; Gori N ; Di Nardo L...
info:eu-repo/semantics/altIdentifier/pmid/34710866. , 2022

Link: https://hdl.handle.net/1..

13

Periocular molluscum contagiosum in an atopic dermatitis pa..:

E. De Luca ; N. Gori ; A. Chiricozzi..
http://dx.doi.org/10.1080/09546634.2022.2104445. , 2022

Link: https://doi.org/10.1080/..

14

Novel Therapeutic Strategies in the Topical Treatment of At..:

Pinto L. M ; Chiricozzi A ; Calabrese L..
info:eu-repo/semantics/altIdentifier/pmid/36559261. , 2022

Link: https://hdl.handle.net/1..

15

Italian adaptation of EuroGuiDerm guideline on the systemic..:

Gisondi P ; Fargnoli M. C ; Amerio P...
info:eu-repo/semantics/altIdentifier/pmid/35262308. , 2022

Link: https://hdl.handle.net/2..